|
 |
Be sure to
listen to Prescription Addiction Radio, Sunday
night at 9pm on WGUL 860am, or live
online at
www.860am.townhall.com
Successes From a
Recent Patients:
Self-Employed Sales:
(Lortab)
"The Novus program was top notch. I'm glad I came.
I want to acknowledge Frances, Jean, Joe, Monty, Natalie and Hayden.
Food: 5 of 5. It was awesome. Housekeeping: 5 of 5.
I had done the two day rapid detox before and did have success. However, after going through the Novus program, I realize that Novus is a far better situation for detoxing your body. Novus eliminates the shock that your system gets from 2-day detox.
My stay was very comfortable. The staff was more than accommodating and the food was superb. I was among friends here and know that should I ever have a problem in the future I have a great support group to get in contact with.
I will recommend the Novus program to anyone needing a detox program because of the attention and care given to me while here."
|
|
|
Letter To The FDA
By Steve Hayes, Director of Novus Medical Detox Center
|
On January 20, 2008, we will have a new president and a new administration. One of the priorities for the new administration will be to appoint a new head of the FDA. Speaking about his approach to the FDA if confirmed as the Secretary of Health and Human Services, the cabinet member directly responsible for the FDA, former Senator Tom Daschle told a Senate panel, "I want to take ideology and politics as much as humanly possible out of the process and leave the scientists to do their job."
This would be a wonderful thing. Daily we are seeing new revelations that doctors who have endorsed drugs were actually on the payroll of a company making the drug. Independent, scientific and non-biased research is essential if we are going to have confidence in any drug.
The excellent well-researched and documented letter below was written by Pete Jackson. Pete and his wife Ellen lost their daughter to an OxyContin overdose and have both been tireless advocates of stopping the abuses of this terrible drug. The letter is addressed to Dr. Woodcock. Dr. Woodcock has distinguished herself by being the advocate when drug industry interests conflict with consumer safety. She advocated and defended keeping Vioxx on the market even though the evidence was overwhelming that it was causing deaths and harm in huge numbers.
As reported in the January 9, 2008 WALL STREET JOURNAL, "On Nov. 14, 2004, she stated: 'There was more bleeding with naproxen, and more cardiovascular events with Vioxx. If you look at the numbers, it's a wash.' She said the FDA and its outside experts decided the balance of gastrointestinal benefit and heart risk justified keeping the drug on the market. Dr. Woodcock is among the agency's powerful administrative officers who tried to silence safety scientists--including David Graham, MD--who brought to light the lethal hazards of drugs such as Vioxx."
Knowing this about Dr. Woodcock, it is hardly surprising that she did little to address Pete's concerns. Here is the letter that he sent.
November 22, 2007
Janet Woodcock, M.D.
Acting Director, Center for Drug Evaluation and Research
Food and Drug Administration
5600 Fishers Lane
Rockville, MD 20857
RE: OxyContin and Prescription Opioid Drug Abuse
Dear Dr. Woodcock,
In August of 2006 our 18 year-old daughter Emily died of an accidental overdose of OxyContin. Emily was a wonderful girl with a sweet disposition and her whole life ahead of her, but she made one simple mistake and now she is gone. Like many kids today, Emily apparently made an assumption that a prescription drug that is FDA-approved and prescribed by a doctor must be safe. Our best efforts to educate our kids as to the dangers of drug abuse were not enough to avert this tragic outcome. I am enclosing her picture so you can look into her eyes and see the innocence in her soul. I would like you to understand that if this can happen to someone like Emily, this can happen to anyone's kid. We must do a better job of protecting our children and other family members. I am asking for your help.
To read on, click here.
|
|
|
|
